Endocrinology
Advanced Endocrinology and Diabetes for Lifelong Hormonal Health.
Evidence-based care for diabetes, thyroid, adrenal, pituitary, and bone disorders.
Endocrinology at Burjeel Medical City offers comprehensive evaluation and management of hormonal and metabolic disorders, ranging from type 1 diabetes in children to adrenal tumors in adults. Our multidisciplinary collaboration with cardiology, nephrology, surgery, and nutrition ensures seamless, patient-centered care grounded in the latest research and international guidelines.
18
fellowship-trained endocrinologists
9,400
patient visits annually
87%
of diabetes patients reach HbA1c < 7% within 6 months
1
Nationally accredited Thyroid Cancer Center
Common Conditions & Subspecialty Clinics.
- Obesity
- Physiotherapy and occupational therapy
- Metabolic associated steatohepatitis (MASH)
- Endocrine secondary hypertension
- Syndrome of inappropriate antidiuretic hormone (SIADH)
- Hyperkalemia or hypokalemia due to endocrine causes
- MEN 1
- MEN 2A
- MEN 2B
- von Hippel–Lindau disease
- Neurofibromatosis type 1
- Insulinoma
- Gastrinoma
- Glucagonoma
- VIPoma
- Somatostatinoma
- Pancreatic neuroendocrine tumor (pNET)
- Paraganglioma
- Familial hypercholesterolemia
- Combined hyperlipidemia
- Mixed dyslipidemia
- Severe hypertriglyceridemia
- Primary ovarian insufficiency
- Amenorrhea
- Hirsutism
- Menopausal syndrome
- Male infertility due to hypogonadism
- Gynecomastia
- Abnormal uterine bleeding (AUB)
- Osteopenia
- Paget’s disease of bone
- Osteomalacia
- Chronic kidney disease–mineral bone disorder (CKD-MBD)
- Prolactinoma
- Acromegaly
- Growth hormone deficiency
- Hypopituitarism
- Non-functioning pituitary adenoma
- Diabetes insipidus
- Craniopharyngioma
- Cushing syndrome
- Addison disease
- Congenital adrenal hyperplasia
- Primary aldosteronism (Conn syndrome)
- Pheochromocytoma
- Adrenal incidentaloma
- Adrenal carcinoma
- Papillary thyroid carcinoma
- Follicular thyroid carcinoma
- Medullary thyroid carcinoma
- Anaplastic thyroid carcinoma
- Parathyroid adenoma
- Parathyroid hyperplasia
- Pelvic inflammatory disease (PID)
- Hashimoto’s thyroiditis
- Painful menstruation (dysmenorrhea)
- Graves’ disease
- Painless thyroiditis
- Postpartum thyroiditis
- Thyroid nodules
- Multinodular goiter
- Toxic adenoma
- Type 1 diabetes
- Feeding and speech therapy
- Latent autoimmune diabetes in adults (LADA)
- Gestational diabetes
- Maturity-onset diabetes of the young (MODY)
- Prediabetes
- Metabolic syndrome
Procedures & Treatments.
-
Genetic testing panels for MODY, MEN syndromes, familial hypercholesterolemia
-
24-hour urine free cortisol, catecholamines, metanephrines, and fractionated plasma metanephrines
-
HbA1c point-of-care testing and oral / intravenous glucose tolerance tests
-
DXA-based body composition analysis
-
Dual-energy X-ray absorptiometry (DXA)
for bone mineral density and vertebral fracture assessment
-
Adrenal and renal vein sampling for endocrine hypertension
-
Inferior petrosal sinus sampling for occult Cushing disease
-
Contrast-enhanced pituitary MRI and dedicated adrenal CT/MRI protocols
-
I-123 / I-131 SPECT/CT for thyroid cancer surveillance
-
Radionuclide thyroid uptake and scan (I-123 or technetium-99m)
-
High-resolution thyroid ultrasound with elastography and ultrasound-guided fine-needle aspiration biopsy (FNA)
-
Dynamic endocrine tests (ACTH stimulation
low- and high-dose dexamethasone suppression, CRH stimulation, insulin tolerance, water-deprivation, growth-hormone stimulation)
-
Continuous glucose monitoring (CGM) profiling and download analysis
-
Comprehensive metabolic and endocrine hormone panels (serum, urine, saliva)
-
Medical nutrition therapy and structured diabetes self-management education (DSME)
-
Anti-obesity pharmacotherapy (orlistat, GLP-1 / GIP-GLP-1 dual agonists, naltrexone-bupropion, phentermine-topiramate, setmelanotide)
-
Statins, PCSK9 inhibitors, ezetimibe, fibrates, niacin, and bempedoic acid for dyslipidemia
-
Testosterone, estrogen-progesterone, and selective androgen receptor modulators (SARMs) for hormone replacement therapy
-
Bisphosphonates, denosumab, teriparatide, romosozumab, and selective estrogen receptor modulators (SERMs) for osteoporosis
-
Somatostatin analogs, growth-hormone receptor antagonists, and PEG-visomant for acromegaly
-
Dopamine agonists (cabergoline, bromocriptine) for prolactinomas
-
Mineralocorticoid receptor antagonists
or targeted therapy (e.g., eplerenone) for primary aldosteronism
-
Glucocorticoid and mineralocorticoid replacement for adrenal insufficiency
-
Radioactive iodine ablation for hyperthyroidism and differentiated thyroid cancer
-
Antithyroid medications (methimazole, propylthiouracil) with beta-blocker preparation for symptom control
-
Thyroid hormone replacement (levothyroxine, liothyronine) and combination therapy when indicated
-
Sodium-glucose cotransporter 2 (SGLT2) inhibitors for cardiorenal protection
-
Injectable antihyperglycemic agents (GLP-1 receptor agonists, dual-incretin agonists, amylin analogs, once-weekly insulin)
-
Oral antihyperglycemic agents (metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors)
-
Intensive insulin therapy (multiple daily injections) and continuous subcutaneous insulin infusion (CSII) with hybrid closed-loop systems
-
Intra-operative neural monitoring (IONM) and nerve integrity assessment during thyroid and parathyroid surgery (with ENT / Head & Neck Surgery)
-
Bariatric surgical and endoscopic procedures (sleeve gastrectomy, Roux-en-Y gastric bypass, endoscopic sleeve gastroplasty) as part of the Medical Weight Management pathway
-
Endoscopic transsphenoidal pituitary tumor resection and stereotactic radiosurgery (Gamma Knife / CyberKnife) for residual disease (with Neurosurgery)
-
Image-guided percutaneous vertebral augmentation for fracture stabilization in severe osteoporosis
-
Laparoscopic and retroperitoneoscopic adrenalectomy for functional/malignant adrenal lesions
-
Image-guided percutaneous vertebral augmentation for fracture stabilization in severe osteoporosis
-
Laparoscopic and retroperitoneoscopic adrenalectomy for functional/malignant adrenal lesions
-
Selective parathyroid venous sampling and minimally invasive parathyroidectomy (with Endocrine Surgery)
-
Microwave or radiofrequency ablation of adrenal and pancreatic neuroendocrine tumors (in collaboration with Interventional Radiology)
-
Ultrasound-guided ethanol and radiofrequency ablation (RFA) of benign thyroid nodules and cysts
Care Pathway & Coordination.
1
Initial Consultation & Baseline Testing
Complete history, exam, labs, and imaging reviewed in a single visit.
2
Integrated Case Review
Endocrinologist, dietitian, diabetes educator, and pharmacist refine a personalized plan.
3
Therapy Initiation & Digital Monitoring
Medication optimization, CGM enrollment, and lifestyle coaching via patient portal.
4
Follow-up & Long-Term Surveillance
Ninety-day outcome check, annual screening schedule, and rapid return if parameters drift.
Technology & Facilities.
-
Hybrid Closed-Loop Insulin Pumps
Automated insulin delivery with real-time glucose feedback.
-
I-123 SPECT/CT Thyroid Imaging
Detects residual tissue with 97% sensitivity.
-
DEXA-Based Body Composition Lab
Precise fat-mass versus lean-mass analysis in six minutes.
-
On-Site Endocrine Laboratory
Comprehensive hormone assays with 24-hour turnaround.
